Dashboard
Manage Tickers

NNVC


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

nanoviricides-considers-nv-387-for-mpox-treatment-under-who-protocol-amid-global-outbreak
NanoViricides Considers NV-387 for MPOX Tr...
08/26/2024 11:39:54

NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicin...

nanoviricides-nv-387-aims-to-tackle-rsv-covid-and-flu-in-upcoming-clinical-trials
NanoViricides' NV-387 Aims to Tackle RSV, ...
08/19/2024 10:36:57

NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicin...

nanoviricides-provides-an-update-on-its-clinical-program-and-strategy-in-its-letter-to-shareholder-says-nv-387-an-antiviral-drug-could-be-as-revolutionary-as-antibiotics
NanoViricides Provides An Update On Its Cl...
08/08/2024 11:46:45

nanoviricides-discusses-its-development-program-for-nv-387-has-shown-activity-against-many-respiratory-viral-infections-in-animal-models-enabling-human-clinical-trials-for-a-number-of-indications
NanoViricides Discusses Its Development Pr...
07/11/2024 13:26:57

NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicin...

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 16:32:10

nanoviricides-reports-that-the-ultra-broad-spectrum-antiviral-nv-387-a-phase-2-stage-drug-candidate-was-found-to-be-effective-in-protecting-lungs-from-damage-in-a-lethally-infected-influenza-h3n2-mouse-model
Nanoviricides Reports That The Ultra-broad...
06/20/2024 10:35:26

why-ammo-shares-are-trading-lower-by-over-19-here-are-other-stocks-moving-in-fridays-mid-day-session
Why AMMO Shares Are Trading Lower By Over ...
06/14/2024 18:13:08

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/14/2024 16:31:56

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
06/12/2024 16:31:05

nanoviricides-nv-387-results-show-flat-blood-concentration-profile-for-prolonged-antiviral-effect-in-clinical-trials
NanoViricides' NV-387 Results Show Flat Bl...
06/11/2024 10:43:13

A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID,...

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
06/10/2024 16:31:08

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
06/05/2024 20:31:22

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
06/04/2024 20:31:10

nanoviricides-reports-on-the-highly-desirable-blood-concentration-profile-of-its-lead-clinical-stage-broad-spectrum-antiviral-agent-nv-387-upon-intravenous-administration-in-a-non-human-primate-animal-model
NanoViricides Reports On The Highly Desira...
06/04/2024 11:03:17

The Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus i...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
06/03/2024 20:31:11

nanoviricides-elaborates-on-its-development-of-a-first-in-class-broad-spectrum-antiviral-agent-that-could-revolutionize-treatment-of-viral-infections-including-rsv-covid-influenzas-and-other-viruses
NanoViricides Elaborates On Its Developmen...
05/29/2024 10:38:55

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
05/16/2024 16:31:11

nanoviricides-reports-breakthrough-in-treating-airborne-viruses-boosting-lifespan-in-infected-mice
NanoViricides Reports Breakthrough in Trea...
05/08/2024 10:37:41

 NanoViricides, Inc. (NYSE:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that ...

ef-hutton-reiterates-buy-on-nanoviricides-maintains-65-price-target
EF Hutton Reiterates Buy on Nanoviricides,...
05/07/2024 13:51:38

EF Hutton analyst Tim Moore reiterates Nanoviricides (AMEX:NNVC) with a Buy and maintains $6.5 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION